Stay updated on Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.

Latest updates to the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page
- Check6 days agoChange DetectedA new version entry dated 2026-02-13 was added, with QC status 'Has Not Concluded', and the record history now displays additional sections such as Adverse Events, Outcome Measures, Baseline Characteristics, and Participant Flow.SummaryDifference0.9%

- Check13 days agoChange DetectedAdded a new history entry: Revision: v3.4.2. The deletions remove the funding notice and the prior Revision: v3.4.1 entry.SummaryDifference0.5%

- Check21 days agoChange DetectedThe History now shows 'Results Submitted' with Revision 3.4.1, replacing the previous 'No Results Posted' (Revision 3.4.0). A government funding notice about the site's operation is displayed.SummaryDifference0.5%

- Check28 days agoChange DetectedThe history page adds a glossary toggle, uses color-coded indicators for additions and deletions, and updates the revision label from v3.3.4 to v3.4.0.SummaryDifference0.6%

- Check42 days agoChange DetectedA new revision entry, v3.3.4, was added to the Record History, following the previous v3.3.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe history now includes a new entry Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig vs Nivolumab in Esophageal SCC Clinical Trial page.